PAR

PAR DRUGS & CHEMICALS

Small Cap NSE: PAR
₹157.00
As on 07 December, 2022 | 14:53

Par Drugs & Chemicals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in PAR DRUGS & CHEMICALS

Start SIP

Par Drugs & Chemicals Share Price

Par Drugs & Chemicals Share Returns

  • Over 1 Month 5.62%
  • Over 3 Month -10.67%
  • Over 6 Month 5.44%
  • Over 1 Year -17.22%

Par Drugs & Chemicals Key Statistics

P/E Ratio 18.3
PEG Ratio -3.3
Market Cap Cr 193
Price to Book Ratio 3.2
EPS 7.5
Dividend 0
Relative Strength Index 48.26
Money Flow Index 39.54
MACD Signal 0.72
Average True Range 6.71

Par Drugs & Chemicals Investment Rating

  • Master Rating:
  • Par Drugs and Chemicals has an operating revenue of Rs. 87.32 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 17% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 21% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 63 which is a FAIR score but needs to improve its earnings, a RS Rating of 30 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 129 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Par Drugs & Chemicals Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 25242217201616
Operating Expenses Qtr Cr 19201813161212
Operating Profit Qtr Cr 6454444
Depreciation Qtr Cr 1111111
Interest Qtr Cr 0000000
Tax Qtr Cr 1111111
Net Profit Qtr Cr 4222224

Par Drugs & Chemicals Technicals

EMA & SMA

Current Price
157.
(0%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 158.29
  • 50 Day
  • 158.46
  • 100 Day
  • 159.93
  • 200 Day
  • 158.94
  • 20 Day
  • 161.46
  • 50 Day
  • 155.52
  • 100 Day
  • 163.82
  • 200 Day
  • 159.73

Par Drugs & Chemicals Resistance and Support

PIVOT
₹157.62
Resistance
First Resistance 158.89
Second Resistance 160.77
Third Resistance 162.04
RSI 48.26
MFI 39.54
MACD Single Line 0.72
Support
First Resistance 155.74
Second Resistance 154.47
Third Resistance 152.59

Par Drugs & Chemicals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 4,895 308,287 62.98
Week 10,548 679,001 64.37
1 Month 35,998 1,858,224 51.62
6 Month 23,357 1,091,918 46.75

Par Drugs & Chemicals Result Highlights

Par Drugs & Chemicals Synopsis

NSE-Medical-Diversified

Par Drugs & Chemical is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 75.07 Cr. and Equity Capital is Rs. 12.30 Cr. for the Year ended 31/03/2022. Par Drugs & Chemicals Ltd. is a Public Limited Listed company incorporated on 26/02/1999 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24117GJ1999PLC035512 and registration number is 035512.
Market Cap 194
Sales 87
Shares in Float 0.32
No of funds 1
Yield 0.72
Book Value 3.23
U/D Vol ratio 0.8
LTDebt / Equity 8
Alpha -0.04
Beta 0.43

Par Drugs & Chemicals

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 74.21%74.21%74.21%
Others 25.79%25.79%25.79%

Par Drugs & Chemicals Management

Name Designation
Mr. Falgun Vallabhbhai Savani Chairman & Managing Director
Mr. Jignesh Vallabhbhai Savani Executive Director & CEO
Mr. Ghanshayambhai Bhagvanbhai Savani Whole Time Director
Mrs. Nayna Jignesh Savani Non Executive Director
Mr. Pravin Manjibhai Bhayani Independent Director
Mrs. Kajal Chintanbhai Vaghani Independent Director
Mr. Krishna Mitulbhai Shah Independent Director
Mrs. Bintal Bhaveshkumar Shah Independent Director

Par Drugs & Chemicals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Par Drugs & Chemicals Corporate Action

Date Purpose Remarks
2022-11-09 Quarterly Results
2022-07-28 Others
2022-05-07 Audited Results
2022-02-07 Quarterly Results
2021-11-09 Quarterly Results & Interim Dividend
Date Purpose Remarks
2021-04-28 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-.

Par Drugs & Chemicals FAQs

What is Share Price of Par Drugs & Chemicals ?

Par Drugs & Chemicals share price is ₹157 As on 07 December, 2022 | 14:39

What is the Market Cap of Par Drugs & Chemicals ?

The Market Cap of Par Drugs & Chemicals is ₹193.2 Cr As on 07 December, 2022 | 14:39

What is the P/E ratio of Par Drugs & Chemicals ?

The P/E ratio of Par Drugs & Chemicals is 18.3 As on 07 December, 2022 | 14:39

What is the PB ratio of Par Drugs & Chemicals ?

The PB ratio of Par Drugs & Chemicals is 3.2 As on 07 December, 2022 | 14:39

Q2FY23